Value of Information: A Tool to Improve Research Prioritization and Reduce Waste

被引:35
作者
Minelli, Cosetta [1 ]
Baio, Gianluca [2 ]
机构
[1] Univ London Imperial Coll Sci Technol & Med, NHLI, Resp Epidemiol Occupat Med & Publ Hlth, London, England
[2] UCL, Dept Stat Sci, London, England
来源
PLOS MEDICINE | 2015年 / 12卷 / 09期
关键词
TECHNOLOGY; DISEASE;
D O I
10.1371/journal.pmed.1001882
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页数:5
相关论文
共 26 条
  • [1] [Anonymous], 2015, Global Strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease
  • [2] Bedding A., 2004, PHARM STAT, P406, DOI [DOI 10.1002/PST.130, 10.1002/pst.130,3(3),230-231.http://www.wileyeurope.com/WileyCDA/WileyTitle]
  • [3] Identifying research priorities: The value of information associated with repeat screening for age-related macular degeneration
    Bojke, Laura
    Claxton, Karl
    Sculpher, Mark J.
    Palmer, Stephen
    [J]. MEDICAL DECISION MAKING, 2008, 28 (01) : 33 - 43
  • [4] Buxton M, 1996, J Health Serv Res Policy, V1, P35
  • [5] Value-of-Information Analysis within a Stakeholder-Driven Research Prioritization Process in a US Setting: An Application in Cancer Genomics
    Carlson, Josh J.
    Thariani, Rahber
    Roth, Josh
    Gralow, Julie
    Henry, N. Lynn
    Esmail, Laura
    Deverka, Pat
    Ramsey, Scott D.
    Baker, Laurence
    Veenstra, David L.
    [J]. MEDICAL DECISION MAKING, 2013, 33 (04) : 463 - 471
  • [6] How to increase value and reduce waste when research priorities are set
    Chalmers, Iain
    Bracken, Michael B.
    Djulbegovic, Ben
    Garattini, Silvio
    Grant, Jonathan
    Guelmezoglu, A. Metin
    Howells, David W.
    Ioannidis, John P. A.
    Oliver, Sandy
    [J]. LANCET, 2014, 383 (9912) : 156 - 165
  • [7] Claxton K, 1996, HEALTH ECON, V5, P513, DOI 10.1002/(SICI)1099-1050(199611)5:6<513::AID-HEC237>3.0.CO
  • [8] 2-9
  • [9] Using value of information analysis to prioritise health research - Some lessons from recent UK experience
    Claxton, Karl P.
    Sculpher, Mark J.
    [J]. PHARMACOECONOMICS, 2006, 24 (11) : 1055 - 1068
  • [10] Prioritizing investments in health technology assessment -: Can we assess potential value for money?
    Davies, L
    Drummond, M
    Papanikolaou, P
    [J]. INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2000, 16 (01) : 73 - 91